StockData
RTGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

RetinalGenix Technologies Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.99+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$75.04M
P/E (TTM)
–
Dividend yield
–

RetinalGenix Technologies Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

RetinalGenix Technologies does not break out revenue by segment, region or product in the tagged data of its filings for this period type.